P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia.

Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J (1997) 1.65

Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care (2002) 1.59

The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. Biochimie (2010) 1.30

Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun (2003) 1.20

An endothelial storage granule for tissue-type plasminogen activator. J Cell Biol (1997) 1.10

Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut (1995) 1.09

CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol (1994) 1.09

Effects of a new C5a receptor antagonist on C5a- and endotoxin-induced neutropenia in the rat. Br J Pharmacol (1999) 0.96

Increased survival and reduced neutrophil infiltration of the liver in Rab27a- but not Munc13-4-deficient mice in lipopolysaccharide-induced systemic inflammation. Infect Immun (2011) 0.92

Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. Am J Pathol (1999) 0.91

Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia. PLoS One (2010) 0.86

Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury. J Clin Invest (1999) 0.85

Anticoagulant modulation of inflammation in severe sepsis. World J Crit Care Med (2015) 0.84

Recombinant tumour necrosis factor-alpha and platelet-activating factor synergistically increase intercellular adhesion molecule-1 and E-selectin-dependent neutrophil adherence to endothelium in vitro. Immunology (1996) 0.82

Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis. Am J Pathol (1995) 0.81

P-selectin requirement for neutrophil accumulation and injury in the direct passive Arthus reaction. Clin Exp Immunol (1998) 0.79

Endogenous glucocorticoids modulate experimental anti-glomerular basement membrane glomerulonephritis. Clin Exp Immunol (2000) 0.77

PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage. Ann Rheum Dis (1997) 0.77

Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model. Arterioscler Thromb Vasc Biol (2015) 0.76

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28

Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell (1991) 13.70

Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell (1991) 11.89

Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature (1990) 5.17

Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons. Cell (1992) 3.80

Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol (1991) 3.05

PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood (1989) 2.86

Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140). J Clin Invest (1992) 2.47

The release of platelet-activating factor from human endothelial cells in culture. J Immunol (1983) 2.41

Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest (1991) 2.17

Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest (1987) 1.96

GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem (1991) 1.62

CV-3988 - a specific antagonist of platelet activating factor (PAF). Life Sci (1983) 1.52

Molecular cloning and analysis of in vivo expression of murine P-selectin. Blood (1992) 1.44

Selective depletion of rat neutrophils by in vivo administration of a monoclonal antibody. J Leukoc Biol (1989) 1.43

Neutrophil leukocyte emigration induced by endotoxin. Mediator roles of interleukin 1 and tumor necrosis factor alpha 1. J Immunol (1988) 1.39

Leukocyte interactions mediated by selectins. Thromb Haemost (1991) 1.34

Mechanisms of lipopolysaccharide-induced neutrophil retention. Relative contributions of adhesive and cellular mechanical properties. J Immunol (1992) 1.34

Role of cytokines and platelet-activating factor in microvascular immune injury. Int Arch Allergy Appl Immunol (1989) 0.98

Neutrophil adherence induced by lipopolysaccharide in vitro. Role of plasma component interaction with lipopolysaccharide. J Clin Invest (1992) 0.93

Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression. J Exp Med (1992) 0.85

Modification of human thrombin: effect on thrombomodulin binding. Thromb Haemost (1988) 0.83

Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells. J Immunol (1989) 0.82

PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science (1990) 5.28

Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol (2001) 3.76

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med (1992) 3.57

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A (1999) 3.07

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med (1999) 2.74

CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med (1995) 2.48

Barriers to xenotransplantation. Nat Med (1995) 2.44

Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med (2000) 2.31

Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann Neurol (2000) 2.30

Bernard-Soulier syndrome. Blood (1998) 2.29

Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol (2001) 2.10

A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest (1998) 2.08

Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest (1999) 1.84

Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines. J Immunol (1987) 1.77

The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med (1999) 1.76

Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65

Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med (1997) 1.62

GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem (1991) 1.62

Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science (1990) 1.54

Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A (1996) 1.51

Antigenic heterogeneity of human mononuclear phagocytes: immunohistologic analysis using monoclonal antibodies. Blood (1983) 1.48

PETA-3/CD151, a member of the transmembrane 4 superfamily, is localised to the plasma membrane and endocytic system of endothelial cells, associates with multiple integrins and modulates cell function. J Cell Sci (1999) 1.47

Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant (2008) 1.47

Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol (1997) 1.46

Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. J Thorac Cardiovasc Surg (1998) 1.46

Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest (2000) 1.44

Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. Transplantation (2000) 1.43

Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease. J Thromb Haemost (2008) 1.42

Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation (2001) 1.42

Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost (2007) 1.41

Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. Eur J Biochem (1985) 1.40

The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity (2000) 1.40

Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol (1994) 1.40

Glycoprotein Ib-IX-V. Int J Biochem Cell Biol (2003) 1.38

Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med (1997) 1.38

Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells (1998) 1.37

Identification of a novel integrin beta subunit expressed on cultured monocytes (macrophages). Evidence that one alpha subunit can associate with multiple beta subunits. J Biol Chem (1990) 1.36

Structure of the glycoprotein Ib.IX complex from platelet membranes. J Biol Chem (1988) 1.35

Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution. J Cell Biol (1992) 1.34

Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol (1993) 1.34

Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptors. Am J Pathol (1986) 1.33

Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur J Immunol (2000) 1.33

Immunophenotypic characterization of the cutaneous exanthem of SIV-infected rhesus monkeys. Apposition of degenerative Langerhans cells and cytotoxic lymphocytes during the development of acquired immunodeficiency syndrome. Am J Pathol (1987) 1.32

Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest (2001) 1.31

Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today (1997) 1.31

Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol (1993) 1.30

P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J Biol Chem (1995) 1.29

Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3) using a reconstituted mammalian cell expression model. J Cell Biol (1999) 1.29

Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med (1992) 1.28

Adhesion protein GMP140 inhibits superoxide anion release by human neutrophils. Proc Natl Acad Sci U S A (1991) 1.28

Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated signaling. Blood (2001) 1.28

PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis. Immunity (1999) 1.27

Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation (1995) 1.25

Identification of a membrane skeleton in platelets. J Cell Biol (1988) 1.25

CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol (1995) 1.25

Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V. J Biol Chem (1981) 1.24

Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex. Blood (2000) 1.24

Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest (1996) 1.24

Pubertal timing and self-reported delinquency among male adolescents. J Adolesc (1999) 1.24

Delayed xenograft rejection. Immunol Today (1996) 1.23

Beneficial effects of targeting CCR5 in allograft recipients. Transplantation (2001) 1.22

Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation (1998) 1.22

Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation (1999) 1.22

Binding of the von Willebrand factor A1 domain to histone. Thromb Res (1997) 1.21

Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions. Blood (2001) 1.21

Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex. Biochemistry (1998) 1.21

Molecular cloning of cDNA encoding a novel platelet-endothelial cell tetra-span antigen, PETA-3. Blood (1995) 1.21

A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding. J Biol Chem (1995) 1.21

P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: studies in glomerulonephritis and cutaneous delayed-type hypersensitivity. Eur J Immunol (1996) 1.19

Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation (1983) 1.19

Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry (1989) 1.18

Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation (1995) 1.17

Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood (1996) 1.17

Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice. Ann N Y Acad Sci (2000) 1.17

Membrane antigens of human cells of the monocyte/macrophage lineage studied with monoclonal antibodies. Pathology (1983) 1.17

Signals from platelet/endothelial cell adhesion molecule enhance the adhesive activity of the very late antigen-4 integrin of human CD34+ hemopoietic progenitor cells. J Immunol (1994) 1.16

Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood (1994) 1.16

A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int (1994) 1.16

Immunohistological studies with monoclonal antibodies. Methods Enzymol (1986) 1.16

Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system. Transplantation (1985) 1.16

A comparison of fixatives and immunohistochemical technics for use with monoclonal antibodies to cell surface antigens. Am J Clin Pathol (1982) 1.15

The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J Cell Biol (2001) 1.15

Monoclonal antibodies to identify tumour cells in CSF. Lancet (1983) 1.15

Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. J Immunol (1987) 1.13

The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets. J Thromb Haemost (2004) 1.13

Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood (1987) 1.13

Platelet GPIb-IX-V-dependent signaling. J Thromb Haemost (2005) 1.12

Analysis of intragraft effector mechanisms associated with human renal allograft rejection: immunohistological studies with monoclonal antibodies. Immunol Rev (1984) 1.12

Additional glycoprotein defects in Bernard-Soulier's syndrome: confirmation of genetic basis by parental analysis. Blood (1983) 1.11

Invading squamous cell carcinoma can retain a basal lamina. An immunohistochemical study using a monoclonal antibody to type IV collagen. Lab Invest (1984) 1.11

Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). Blood (1995) 1.11

Phosphoinositide 3-kinase forms a complex with platelet membrane glycoprotein Ib-IX-V complex and 14-3-3zeta. Blood (2000) 1.11

Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. Mol Cell (2000) 1.10

A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site. J Biol Chem (1992) 1.10

Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Natl Acad Sci U S A (1992) 1.10

Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med (1995) 1.10